Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ossicular Replacement | 4 | 2024 | 7 | 2.710 |
Why?
|
| Temporal Bone | 9 | 2020 | 60 | 2.440 |
Why?
|
| Meniere Disease | 4 | 2023 | 14 | 2.090 |
Why?
|
| Mastoid | 5 | 2020 | 16 | 1.990 |
Why?
|
| Presbycusis | 3 | 2020 | 11 | 1.790 |
Why?
|
| Hearing Loss, Conductive | 5 | 2021 | 15 | 1.780 |
Why?
|
| Hearing | 5 | 2024 | 58 | 1.530 |
Why?
|
| Tinnitus | 4 | 2016 | 22 | 1.520 |
Why?
|
| Cochlear Implantation | 7 | 2020 | 33 | 1.360 |
Why?
|
| Ear Diseases | 3 | 2017 | 21 | 1.350 |
Why?
|
| Ear Canal | 3 | 2014 | 16 | 1.230 |
Why?
|
| Cochlear Implants | 6 | 2019 | 36 | 1.210 |
Why?
|
| Hearing Loss, Sensorineural | 6 | 2020 | 48 | 1.180 |
Why?
|
| Ossicular Prosthesis | 3 | 2020 | 5 | 1.150 |
Why?
|
| Postoperative Complications | 6 | 2024 | 2453 | 1.070 |
Why?
|
| Stapes Surgery | 2 | 2021 | 6 | 1.060 |
Why?
|
| Hearing Loss | 3 | 2016 | 63 | 1.020 |
Why?
|
| Ear Neoplasms | 2 | 2017 | 13 | 1.010 |
Why?
|
| Audiometry, Pure-Tone | 8 | 2024 | 26 | 1.000 |
Why?
|
| Facial Nerve | 2 | 2019 | 33 | 0.970 |
Why?
|
| Otitis Media with Effusion | 2 | 2018 | 6 | 0.960 |
Why?
|
| Eustachian Tube | 2 | 2018 | 9 | 0.950 |
Why?
|
| Temporal Arteries | 2 | 2015 | 9 | 0.920 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2015 | 8 | 0.890 |
Why?
|
| Ear, Inner | 2 | 2017 | 32 | 0.880 |
Why?
|
| Endolymphatic Hydrops | 2 | 2023 | 4 | 0.870 |
Why?
|
| Otologic Surgical Procedures | 5 | 2015 | 13 | 0.870 |
Why?
|
| Surgical Flaps | 2 | 2015 | 254 | 0.770 |
Why?
|
| Intraoperative Complications | 2 | 2020 | 189 | 0.770 |
Why?
|
| Hearing Aids | 2 | 2013 | 8 | 0.770 |
Why?
|
| Humans | 53 | 2024 | 92310 | 0.700 |
Why?
|
| Mastoidectomy | 1 | 2020 | 3 | 0.690 |
Why?
|
| Hydroxyapatites | 1 | 2020 | 7 | 0.690 |
Why?
|
| Child | 16 | 2024 | 7309 | 0.660 |
Why?
|
| Mucous Membrane | 2 | 2018 | 84 | 0.640 |
Why?
|
| Cholesteatoma | 2 | 2017 | 7 | 0.630 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 69 | 0.620 |
Why?
|
| Retrospective Studies | 17 | 2024 | 9690 | 0.610 |
Why?
|
| Treatment Outcome | 13 | 2024 | 8728 | 0.600 |
Why?
|
| Cranial Fossa, Middle | 1 | 2018 | 12 | 0.600 |
Why?
|
| Middle Aged | 25 | 2024 | 27039 | 0.600 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2018 | 28 | 0.590 |
Why?
|
| Superior Olivary Complex | 1 | 2018 | 1 | 0.590 |
Why?
|
| Dilatation | 1 | 2018 | 47 | 0.580 |
Why?
|
| Otitis | 1 | 2018 | 2 | 0.580 |
Why?
|
| Ear, Middle | 2 | 2020 | 26 | 0.580 |
Why?
|
| Stapes | 2 | 2015 | 5 | 0.580 |
Why?
|
| Ciprofloxacin | 1 | 2018 | 30 | 0.570 |
Why?
|
| Craniotomy | 1 | 2018 | 92 | 0.570 |
Why?
|
| Endolymphatic Sac | 1 | 2017 | 2 | 0.560 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2009 | 10 | 0.560 |
Why?
|
| Migraine Disorders | 1 | 2018 | 42 | 0.550 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2017 | 18 | 0.550 |
Why?
|
| Male | 29 | 2024 | 43918 | 0.540 |
Why?
|
| Young Adult | 11 | 2024 | 6629 | 0.540 |
Why?
|
| Adult | 22 | 2024 | 27534 | 0.540 |
Why?
|
| Adolescent | 14 | 2024 | 9495 | 0.540 |
Why?
|
| Vestibular Nerve | 1 | 2017 | 33 | 0.530 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 80 | 0.530 |
Why?
|
| Speech Perception | 3 | 2020 | 72 | 0.520 |
Why?
|
| Fistula | 1 | 2017 | 42 | 0.520 |
Why?
|
| Bone Conduction | 2 | 2013 | 5 | 0.510 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2016 | 3 | 0.500 |
Why?
|
| Osseointegration | 2 | 2013 | 10 | 0.500 |
Why?
|
| Ear Ossicles | 2 | 2013 | 8 | 0.500 |
Why?
|
| Skull Neoplasms | 1 | 2016 | 27 | 0.500 |
Why?
|
| Tympanoplasty | 2 | 2012 | 13 | 0.490 |
Why?
|
| Ossification, Heterotopic | 1 | 2016 | 32 | 0.490 |
Why?
|
| Malleus | 2 | 2012 | 3 | 0.490 |
Why?
|
| Female | 28 | 2024 | 47889 | 0.490 |
Why?
|
| Periosteum | 1 | 2015 | 9 | 0.490 |
Why?
|
| Child, Preschool | 9 | 2024 | 3806 | 0.480 |
Why?
|
| Cranial Sinuses | 1 | 2015 | 15 | 0.480 |
Why?
|
| Glucocorticoids | 3 | 2018 | 367 | 0.470 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 280 | 0.470 |
Why?
|
| Nanocapsules | 1 | 2015 | 11 | 0.460 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 2685 | 0.460 |
Why?
|
| Rhabdomyosarcoma | 1 | 2015 | 42 | 0.460 |
Why?
|
| Indocyanine Green | 1 | 2015 | 24 | 0.460 |
Why?
|
| Diverticulum | 1 | 2015 | 44 | 0.460 |
Why?
|
| Hearing Loss, Unilateral | 2 | 2013 | 3 | 0.460 |
Why?
|
| Incus | 2 | 2012 | 2 | 0.450 |
Why?
|
| Cadaver | 4 | 2019 | 191 | 0.450 |
Why?
|
| Otitis Media | 2 | 2011 | 20 | 0.440 |
Why?
|
| Aged | 18 | 2024 | 19947 | 0.440 |
Why?
|
| Photochemotherapy | 1 | 2015 | 101 | 0.440 |
Why?
|
| Brain Diseases | 1 | 2015 | 186 | 0.430 |
Why?
|
| Ichthyosis, Lamellar | 1 | 2013 | 1 | 0.420 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1270 | 0.400 |
Why?
|
| Laryngeal Diseases | 2 | 2004 | 20 | 0.400 |
Why?
|
| Antibodies | 1 | 2015 | 351 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 808 | 0.390 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 313 | 0.380 |
Why?
|
| Aging | 1 | 2017 | 741 | 0.380 |
Why?
|
| ErbB Receptors | 1 | 2015 | 498 | 0.370 |
Why?
|
| Triamcinolone Acetonide | 1 | 2011 | 8 | 0.360 |
Why?
|
| Nasal Sprays | 1 | 2011 | 9 | 0.360 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 56 | 0.360 |
Why?
|
| Stapes Mobilization | 1 | 2011 | 1 | 0.360 |
Why?
|
| Reoperation | 4 | 2020 | 653 | 0.330 |
Why?
|
| Cochlea | 3 | 2020 | 50 | 0.320 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1072 | 0.310 |
Why?
|
| Auditory Threshold | 3 | 2018 | 15 | 0.290 |
Why?
|
| Spiral Ganglion | 2 | 2018 | 25 | 0.280 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 3776 | 0.260 |
Why?
|
| Chronic Disease | 3 | 2018 | 966 | 0.260 |
Why?
|
| Keratitis | 1 | 2006 | 21 | 0.250 |
Why?
|
| Vestibular Diseases | 1 | 2006 | 28 | 0.250 |
Why?
|
| Parotid Diseases | 1 | 2005 | 5 | 0.240 |
Why?
|
| Hypopharynx | 1 | 2005 | 9 | 0.240 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2005 | 23 | 0.230 |
Why?
|
| Infant | 4 | 2019 | 3206 | 0.230 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1768 | 0.230 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2004 | 18 | 0.220 |
Why?
|
| Tracheal Diseases | 1 | 2004 | 14 | 0.220 |
Why?
|
| Esophageal Diseases | 1 | 2004 | 26 | 0.220 |
Why?
|
| Hearing Tests | 2 | 2014 | 11 | 0.220 |
Why?
|
| Cysts | 1 | 2005 | 103 | 0.220 |
Why?
|
| Biopsy | 2 | 2018 | 1194 | 0.220 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 87 | 0.220 |
Why?
|
| Risk Factors | 4 | 2024 | 5706 | 0.210 |
Why?
|
| Dissection | 2 | 2015 | 43 | 0.210 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2003 | 12 | 0.210 |
Why?
|
| Laryngostenosis | 1 | 2003 | 18 | 0.210 |
Why?
|
| Tympanic Membrane | 2 | 2013 | 13 | 0.200 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2012 | 7 | 0.200 |
Why?
|
| Equipment Failure | 2 | 2013 | 123 | 0.190 |
Why?
|
| Sternoclavicular Joint | 1 | 2001 | 2 | 0.190 |
Why?
|
| Edema | 1 | 2001 | 68 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3514 | 0.170 |
Why?
|
| Dexamethasone | 2 | 2018 | 347 | 0.170 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 19 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 6916 | 0.170 |
Why?
|
| Tracheostomy | 1 | 2000 | 47 | 0.160 |
Why?
|
| Vertigo | 1 | 2020 | 40 | 0.160 |
Why?
|
| Anisotropy | 1 | 2019 | 63 | 0.160 |
Why?
|
| Cochlear Nerve | 1 | 2019 | 9 | 0.150 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 197 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2000 | 238 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 13 | 0.150 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 37 | 0.150 |
Why?
|
| Betahistine | 1 | 2018 | 1 | 0.150 |
Why?
|
| Triamterene | 1 | 2018 | 1 | 0.150 |
Why?
|
| Middle Ear Ventilation | 1 | 2018 | 4 | 0.150 |
Why?
|
| Magnesium Oxide | 1 | 2018 | 4 | 0.150 |
Why?
|
| Electric Impedance | 1 | 2018 | 109 | 0.150 |
Why?
|
| Skull Base | 1 | 2018 | 51 | 0.140 |
Why?
|
| Hydrochlorothiazide | 1 | 2018 | 41 | 0.140 |
Why?
|
| Patient Selection | 2 | 2012 | 689 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2018 | 288 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 1075 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2018 | 206 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 150 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 146 | 0.140 |
Why?
|
| Hair Cells, Auditory | 1 | 2017 | 24 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2017 | 299 | 0.130 |
Why?
|
| Cell Count | 1 | 2017 | 201 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 1733 | 0.130 |
Why?
|
| Syndrome | 2 | 2009 | 449 | 0.130 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2016 | 1 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2011 | 2729 | 0.120 |
Why?
|
| Temporal Muscle | 1 | 2015 | 12 | 0.120 |
Why?
|
| Action Potentials | 1 | 2018 | 604 | 0.110 |
Why?
|
| Keratinocytes | 1 | 2015 | 147 | 0.110 |
Why?
|
| Second-Look Surgery | 1 | 2013 | 6 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 311 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2016 | 405 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 999 | 0.100 |
Why?
|
| Prognosis | 2 | 2015 | 3871 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 794 | 0.100 |
Why?
|
| Glomus Jugulare Tumor | 1 | 2012 | 2 | 0.100 |
Why?
|
| Carotid Body Tumor | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 8 | 0.100 |
Why?
|
| Polyvinyls | 1 | 2012 | 21 | 0.100 |
Why?
|
| Spiral Lamina | 1 | 2011 | 2 | 0.090 |
Why?
|
| Meningitis | 1 | 2011 | 22 | 0.090 |
Why?
|
| Geniculate Ganglion | 1 | 2011 | 2 | 0.090 |
Why?
|
| Telephone | 1 | 2011 | 36 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 295 | 0.090 |
Why?
|
| Fibrosis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Suture Anchors | 1 | 2010 | 6 | 0.090 |
Why?
|
| Logistic Models | 2 | 2012 | 1239 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 211 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.090 |
Why?
|
| Pediatrics | 1 | 2015 | 369 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 359 | 0.080 |
Why?
|
| Endoscopy | 1 | 2013 | 359 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 265 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1593 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2033 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 224 | 0.080 |
Why?
|
| Speech Intelligibility | 1 | 2009 | 10 | 0.080 |
Why?
|
| Retinal Artery Occlusion | 1 | 2009 | 12 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 4471 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 505 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2011 | 1755 | 0.070 |
Why?
|
| Chlorambucil | 1 | 2005 | 23 | 0.060 |
Why?
|
| Dapsone | 1 | 2004 | 10 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2004 | 66 | 0.050 |
Why?
|
| Esophagoscopy | 1 | 2004 | 90 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2010 | 2978 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 22 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 569 | 0.050 |
Why?
|
| Catheterization | 1 | 2004 | 237 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 183 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2001 | 67 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 351 | 0.050 |
Why?
|
| Neurofibromatosis 2 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Otolaryngology | 1 | 2000 | 56 | 0.040 |
Why?
|
| Acoustic Impedance Tests | 1 | 2018 | 3 | 0.040 |
Why?
|
| Data Collection | 1 | 2000 | 379 | 0.040 |
Why?
|
| Telemetry | 1 | 2018 | 36 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2506 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2019 | 191 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 5428 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2365 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 2012 | 4 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2011 | 800 | 0.020 |
Why?
|
| United States | 1 | 2000 | 7348 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2368 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1960 | 0.010 |
Why?
|